𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Implication of mutations in Connexin 31 in cochlear implant outcome

✍ Scribed by Eugene A. Chu; Anand N. Mhatre; Lawrence R. Lustig; Anil K. Lalwani


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
249 KB
Volume
2
Category
Article
ISSN
1438-7506

No coin nor oath required. For personal study only.

✦ Synopsis


Mutations in the gene of the gap junction protein Connexin 31 (CX31; other connexin 1 Laboratory of Molecular genes abbreviated by CX+#, i.e. Connexin 30 = CX30) have been demonstrated to be Otology, Epstein Laboratories, responsible for both autosomal dominant and recessive nonsyndromic hereditary hearing Department of Otolaryngologyimpairment (NHHI). In this study, we assessed the prevalence of CX31 mutations in pa-Head and Neck Surgery, tients who had undergone cochlear implant surgery for profound sensorineural hearing University of California, loss and investigate the potential relationship between sequence alterations in CX31 and San Francisco, CA, USA rehabilitative outcome. The single coding exon of CX31 was amplified by PCR from ge-2 Department of Otolaryngologynomic DNA of cochlear implant patients. Of the 57 patients, 14 patients (25%) had altered Head & Neck Surgery, sequence in CX31; sequence analysis identified 15 single base changes in the 14 for a Johns Hopkins University 13% (15/114) incidence of variant allele frequency in the study population. Four distinct Medical Center, single nucleotide transitions were recognized including: one previously undocumented sin-Baltimore, MA, USA

gle nucleotide transition (250G Ǟ A) that resulted in an amino acid substitution at codon 84 (V84I) and three previously described single nucleotide polymorphisms (SNPs) (94C Ǟ T, 357C Ǟ T, and 798C Ǟ T). A single patient exhibited the 357C Ǟ T SNP in a homozygous state while the remaining patients' sequence variations were heterozygous. The novel V84I amino acid substitution occurred in the conserved second transmembrane domain of CX31 known to be critical for the regulation of voltage gating. However, the biologic consequence of this mutation and how it may relate to hearing loss is unknown. Rehabilitative outcome with cochlear implantation was similar in patients with and without CX31 mutations. Our data suggests that sequence alteration in CX31 is common in patients undergoing cochlear implantation and their rehabilitative outcome is unaffected.


πŸ“œ SIMILAR VOLUMES


Predictability of cochlear implant outco
✍ Anil K. Lalwani; Cameron L. Budenz; Adam S. Weisstuch; James Babb; J. Thomas Rol πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 84 KB

## Abstract ## Objectives: The purpose of this study is to determine if the performance of the first implanted member of a family predicts the performance of subsequently implanted family members. ## Study Design: Retrospective chart review. ## Methods: Seventy‐one cochlear implant recipients,

Outcome of cochlear implantation in asym
✍ Vikas Malik; Iain A. Bruce; Stephen J. Broomfield; Lisa Henderson; Kevin M.J. Gr πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 345 KB

## Abstract ## Objectives/Hypothesis: Congenital cytomegalovirus (cCMV) infection is a common cause of sensorineural hearing loss (SNHL). The incidence of SNHL is higher in symptomatic cCMV infants and is usually identified early. By contrast, the incidence of SNHL is lower in children with asympt

Outcome of cochlear implantation in chil
✍ T Matsui; H Ogawa; N Yamada; Y Baba; M Nomoto; K Omori πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 252 KB

Objective: Congenital cytomegalovirus (CMV) infection accounts for approximately 20% of all cases of neonatal hearing loss, while the GJB2 mutation accounts for 30-50% of all cases of profound nonsyndromic hearing loss in many populations. Here, outcomes for auditory behavior and speech and language